A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease

Ullah, Amin; Din, Ahmad Ud; Ding, Wen; Shi, Zheng; Pervaz, Sadaf; Shen, Bairong

doi:10.1007/s11154-023-09800-w

Cited by 20 publications

(7 citation statements)

References 186 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nonalcoholic steatohepatitis (NASH) is closely related to CXC chemokines, too. CXCL family plays a crucial role in the inflammation development of NASH through recruitment and infiltration of immune cells including macorphages, neutrophiles, natural killer T cells and so on [80]. According to bioinformatics analysis, CXCL2 is one of the key genes associated with NASH [81].…”

Section: Cxcr8mentioning

confidence: 99%

“…In fact, researches associated with the relationship between CXCL family and metabolic diseases are increasing nowadays, since the therapeutic potential of CXCL in metabolic disease are showing to world [80]. CXCL family may perform functions in the process of metabolic diseases via recruitment of immune cells and regulation of inflammation.…”

Section: Metabolic Diseasementioning

confidence: 99%

See 1 more Smart Citation

The role of CXCL family members in different diseases

et al. 2023

View full text Add to dashboard Cite

Chemokines are a large family mediating a lot of biological behaviors including chemotaxis, tumor growth, angiogenesis and so on. As one member of this family, CXC subfamily possesses the same ability. CXC chemokines can recruit and migrate different categories of immune cells, regulate tumor’s pathological behaviors like proliferation, invasion and metastasis, activate angiogenesis, etc. Due to these characteristics, CXCL subfamily is extensively and closely associated with tumors and inflammatory diseases. As studies are becoming more and more intensive, CXCLs’ concrete roles are better described, and CXCLs’ therapeutic applications including biomarkers and targets are also deeply explained. In this review, the role of CXCL family members in various diseases is summarized.

show abstract

Section: Cxcr8mentioning

confidence: 99%

Section: Metabolic Diseasementioning

confidence: 99%

The role of CXCL family members in different diseases

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Moreover, insulin resistance is closely associated with hypertension. Such patients may have visceral fat obesity, secrete a lot of inflammatory cytokines and have chronic smoldering vascular inflammation [ 31 ]. As a result, it is expected that atherosclerosis is progressing.…”

Section: Discussionmentioning

confidence: 99%

Association between Major Adverse Cardiovascular Events and the Liver Fibrosis Score in Patients with and without Coronary Artery Disease: From the FU-CCTA Registry

Ajimu,

Shiga,

Hirata

et al. 2023

JCM

View full text Add to dashboard Cite

The liver fibrosis score reflects the degree of hepatic scarring and has been reported to be associated with cardiovascular disease. Using a coronary artery computed tomography angiography registry at the Fukuoka University Hospital (FU-CCTA registry), we investigated the association between major adverse cardiovascular events (MACEs) and the liver fibrosis score (fibrosis-4 index (FIB-4I)) in 612 patients who underwent CCTA to screen for coronary artery disease and performed a prognosis survey for up to 5 years. The primary endpoint was MACEs (all-cause mortality, acute myocardial infarction, ischemic stroke, coronary revascularization). FIB-4I in all patients and in patients with hypertension (HTN) was significantly higher in the MACE group than in the non-MACE group. The event-free survival rate of MACEs targeting only patients with HTN was significantly lower in patients with a high risk of liver fibrosis (FIB-4I values of 2.67 or higher) than in those with a low or intermediate risk (less than 2.67). However, no significant difference was observed in all patients or in patients without HTN. Finally, FIB-4I and body mass index were independent factors associated with MACEs in patients with HTN. In conclusion, the liver fibrosis score may be an independent predictor of MACEs in hypertensive patients undergoing CCTA.

show abstract

“…We recently discussed the classification of CXC chemokines and their effects on immune surveillance in a number of inflammatory diseases, such as diabetes, nonalcoholic fatty liver disease, liver cancer, endometriosis, and polycystic ovary syndrome. These CXC chemokines function as chemotaxis, attracting immune cells and causing inflammation [ 19 , 20 ]. We will thus have new opportunities for a better understanding of the role of CXC chemokines in the genesis of inflammatory disorders if we have a deeper knowledge of their potential mechanisms in inflammatory disorders and their management.…”

Section: Proinflammatory Cytokines and CXC Chemokinesmentioning

confidence: 99%

The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management

Ullah,

Jiao,

Shen

2024

Cell Mol Biol Lett

Self Cite

View full text Add to dashboard Cite

Reproductive cancers are malignancies that develop in the reproductive organs. One of the leading cancers affecting the male reproductive system on a global scale is prostate cancer (PCa). The negative consequences of PCa metastases endure and are severe, significantly affecting mortality and life quality for those who are affected. The association between inflammation and PCa has captured interest for a while. Inflammatory cells, cytokines, CXC chemokines, signaling pathways, and other elements make up the tumor microenvironment (TME), which is characterized by inflammation. Inflammatory cytokines and CXC chemokines are especially crucial for PCa development and prognosis. Cytokines (interleukins) and CXC chemokines such as IL-1, IL-6, IL-7, IL-17, TGF-β, TNF-α, CXCL1–CXCL6, and CXCL8–CXCL16 are thought to be responsible for the pleiotropic effects of PCa, which include inflammation, progression, angiogenesis, leukocyte infiltration in advanced PCa, and therapeutic resistance. The inflammatory cytokine and CXC chemokines systems are also promising candidates for PCa suppression and immunotherapy. Therefore, the purpose of this work is to provide insight on how the spectra of inflammatory cytokines and CXC chemokines evolve as PCa develops and spreads. We also discussed recent developments in our awareness of the diverse molecular signaling pathways of these circulating cytokines and CXC chemokines, as well as their associated receptors, which may one day serve as PCa-targeted therapies. Moreover, the current status and potential of theranostic PCa therapies based on cytokines, CXC chemokines, and CXC receptors (CXCRs) are examined.

show abstract

A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease

Cited by 20 publications

References 186 publications

The role of CXCL family members in different diseases

The role of CXCL family members in different diseases

Association between Major Adverse Cardiovascular Events and the Liver Fibrosis Score in Patients with and without Coronary Artery Disease: From the FU-CCTA Registry

The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management

Contact Info

Product

Resources

About